F-22Raptor
ELITE MEMBER
- Joined
- Jun 19, 2014
- Messages
- 16,980
- Reaction score
- 3
- Country
- Location
U.S. regulators are poised to tap the brakes on approving dozens of cancer drugs and other new medicines developed in China.
The regulators have expressed concerns about the quality of studies largely conducted in China and whether the results can apply to patients in the U.S.
https://www.wsj.com/amp/articles/fda-raises-concerns-about-china-developed-drugs-11644408180
The regulators have expressed concerns about the quality of studies largely conducted in China and whether the results can apply to patients in the U.S.
https://www.wsj.com/amp/articles/fda-raises-concerns-about-china-developed-drugs-11644408180